Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care

被引:41
|
作者
Jamison, James [1 ]
Graffy, Jonathan [2 ]
Mullis, Ricky [3 ]
Mant, Jonathan [3 ]
Sutton, Stephen [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Behav Sci, Behav Sci Grp, Cambridge CB2 1TN, England
[2] Univ Cambridge, Sch Clin Med, Primary Care Unit, Inst Publ Hlth, Cambridge CB2 1TN, England
[3] Univ Cambridge, Strangeways Res Lab, Primary Care Res, Primary Care Unit, Cambridge CB2 1TN, England
关键词
general practice; medication adherence; qualitative research; secondary prevention; stroke; SURVIVORS; THERAPY; IMPACT; RISK;
D O I
10.3399/bjgp16X685609
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Medications are highly effective at reducing risk of recurrent stroke, but success is influenced by adherence to treatment. Among survivors of stroke and transient ischaemic attack (TIA), adherence to medication is known to be suboptimal. Aim To identify and report barriers to medication adherence for the secondary prevention of stroke/TIA. Design and setting A qualitative interview study was conducted within general practice surgeries in the East of England, UK. Method Patients were approached by letter and invited to take part in a qualitative research study. Semi-structured interviews were undertaken with survivors of stroke, caregivers, and GPs to explore their perspectives and views around secondary prevention and perceived barriers to medication adherence. Key themes were identified using a grounded theory approach. Verbatim quotes describing the themes are presented here. Results In total, 28 survivors of stroke, including 14 accompanying caregivers and five GPs, were interviewed. Two key themes were identified. Patient level barriers included ability to self-care, the importance people attach to a stroke event, and knowledge of stroke and medication. Medication level barriers included beliefs about medication and beliefs about how pills work, medication routines, changing medications, and regimen complexity and burden of treatment. Conclusion Patients who have had a stroke are faced with multiple barriers to taking secondary prevention medications in UK general practice. This research suggests that a collaborative approach between caregivers, survivors, and healthcare professionals is needed to address these barriers and facilitate medication-taking behaviour.
引用
收藏
页码:E568 / E576
页数:9
相关论文
共 50 条
  • [1] Barriers to medication adherence for secondary stroke prevention in rural communities in Cameroon: a qualitative study
    Mundih Noelar Njohjam
    Niakam Tiffany Falonne
    Mark Olivier Ngoule
    BMC Primary Care, 26 (1):
  • [2] Barriers and Facilitators for Medication Adherence in Stroke Patients: A Qualitative Study Conducted in French Neurological Rehabilitation Units
    Bauler, Stephanie
    Jacquin-Courtois, Sophie
    Haesebaert, Julie
    Luaute, Jacques
    Coudeyre, Emmanuel
    Feutrier, Corinne
    Allenet, Benoit
    Decullier, Evelyne
    Rode, Gilles
    Janoly-Dumenil, Audrey
    EUROPEAN NEUROLOGY, 2014, 72 (5-6) : 262 - 270
  • [3] Medication adherence for secondary stroke prevention and its barriers among lebanese survivors: A cross-sectional study
    Saade, Sylvia
    Kobeissy, Rawan
    Sandakli, Salwa
    Malaeb, Diana
    Lahoud, Nathalie
    Hallit, Souheil
    Hosseini, Hassan
    Salameh, Pascale
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 9 : 338 - 346
  • [4] Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study
    Koh, Joel Jun Kai
    Cheng, Rui Xiang
    Yap, Yicheng
    Haldane, Victoria
    Tan, Yao Guo
    Teo, Krichelle Wei Qi
    Srivastava, Aastha
    Ong, Pei Shi
    Perel, Pablo
    Legido-Quigley, Helena
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 2481 - 2498
  • [5] Compliance with recommendations in secondary prevention of stroke in primary care
    Tamayo-Ojeda, Carmen
    Parellada-Esquius, Neus
    Salvador-Gonzalez, Betlem
    Angeles Oriol-Toron, Pilar
    Dolores Rodriguez-Garrido, M.
    Munoz-Segura, Dolores
    ATENCION PRIMARIA, 2017, 49 (06): : 351 - 358
  • [6] A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
    Viprey, Marie
    Gouillet, Mailys
    Puppo, Costanza
    Termoz, Anne
    Della Vecchia, Claire
    Derex, Laurent
    Haesebaert, Julie
    Schott, Anne-Marie
    Preau, Marie
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 1213 - 1223
  • [7] Barriers to secondary fracture prevention in primary care
    Mendis, A. S.
    Ganda, K.
    Seibel, M. J.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 2913 - 2919
  • [8] Understanding barriers to and strategies for medication adherence in COPD: a qualitative study
    O'Toole, Jacqueline
    Krishnan, Meera
    Riekert, Kristin
    Eakin, Michelle N.
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [9] Stroke survivors', caregivers' and GPs' attitudes towards a polypill for the secondary prevention of stroke: a qualitative interview study
    Jamison, James
    Graffy, Jonathan
    Mullis, Ricky
    Mant, Jonathan
    Sutton, Stephen
    BMJ OPEN, 2016, 6 (05):
  • [10] Barriers to medication adherence in a rural-urban dual economy: a multi-stakeholder qualitative study
    Xu, Jacqueline
    Zhao, Mengxi
    Vrosgou, Athina
    Yu, Natalie Chin Wen
    Liu, Chelsea
    Zhang, Han
    Ding, Chunxi
    Roth, Noelle Wyman
    Pan, Yuesong
    Liu, Liping
    Wang, Yilong
    Wang, Yongjun
    Bettger, Janet Prvu
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)